Despite all the great progress made harnessing the immune system to fight cancer, there is still much work to be done to maximize its potential. The latest evidence: disappointing results today from a roughly 1,100-patient study called “Mystic,” a highly anticipated... Read more »
The attempt to repeal and replace the Affordable Care Act took a major hit this week from Senate GOP holdouts who said the Better Care Reconciliation Act either tore down Medicaid too much or left too much of the ACA in... Read more »
The Iron Yard coding school, which has campuses in Dallas, Houston, and Austin, TX, announced Thursday that it is shutting down operations.
In a blog post on the school’s website, communications director Lelia King wrote that “the Iron Yard has made... Read more »
[Updated 7/25/17 5:18 pm. See below.] Houston—Houston, Mission Control has a problem.
The storied control room at NASA’s Johnson Space Center in Houston—recognizable to many of us from 1960s news clips of the dawn of the Space... Read more »
The second episode of Xconomy’s new podcast, Xconomy Voices, features Recorded Future co-founder and CEO Christopher Ahlberg. His Somerville, MA-based cybersecurity company monitors both the public, visible Web and the Internet’s darker corners for “threat intelligence” that can help... Read more »
On our new Xconomy Voices podcast, we find the smartest, most successful entrepreneurs and innovators in Xconomy’s network of cities and regions, and we ask them to open up about what they’re working on, what they’re excited about, and why... Read more »
A regenerative medicine treatment for skin burns developed by Stratatech could make it to the market more quickly following a regulatory decision announced Tuesday.
The FDA has designated StrataGraft, a Stratatech-developed sheet of living tissue made from human cells that form... Read more »
The Internet pioneer Vinton Cerf came to San Diego recently on an unusual quest—to meet with dozens of local technology leaders and assess what the region has to offer in terms of innovation. It was Veni, Vidi, Vinti. He came. He... Read more »
It’s easy to find hope that new biomedical technologies, from genetic sequencing to wearable fitness trackers, will lead to a healthier populace. It’s harder to find evidence. There has even been caution about the idea of analyzing the DNA of seemingly... Read more »
Government and industry are rife with awkward acronyms. Take PDUFA, for example.
First passed in 1992, the Prescription Drug User Fee Act allows the FDA to collect fees from biopharmaceutical companies when they apply for drug approval; those funds are designated... Read more »
The first ever approval of a new kind of cancer immunotherapy called CAR-T is one step closer. A 10-member panel of doctors and researchers who advise the Food and Drug Administration recommended with a rare unanimous vote that the agency approve... Read more »
With influenza season a few months away, Sanofi is giving its vaccine operations a shot in the arm by acquiring Protein Sciences, a company that has a commercial vaccine, Flublok, and manufactures it using genetic engineering and cell culture instead of... Read more »